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Myocardial protection of the hypoxic heart 
To the Editor: 
The study of Bolling and associates 1 on myocardial 
protection in normal and hypoxically stressed hearts in 
this Journal concluded that good myocardial protection is
independent of cardioplegic alcium concentration in 
nonhypoxic hearts and that hypoxic hearts are extremely 
sensitive to the cardioplegic calcium concentration. The 
authors lamented the absence of a clinically relevant 
hypoxic model. This is an important consideration, be- 
cause many children who undergo cardiac operations in 
the first year of life have cyanotic heart disease, and the 
myocardium may be chronically perfused with hypoxic 
blood. Clearly it would be desirable to alter current 
techniques of myocardial management during surgery to 
provide better myocardial protection for children with 
cyanotic ongenital heart disease and to further determine 
whether such techniques might also be applied to adults 
with acyanotic acquired heart disease. If the impact of 
prolonged periods of hypoxia on tolerance to subsequent 
ischemia could be elucidated, cardioprotection i  these 
patients could be better understood and improved. The 
model of acute hypoxia described by Bolling and col- 
leagues, ~which was originally described by Buckberg, 2 
Ihnken, 3 and their associates, does not allow for the 
development of adaptive mechanisms in response to 
chronic hypoxia that occur in children with cyanotic heart 
disease. In addition, it is unknown whether eoxygenation 
is a real source of cardiac dysfunction in the chronically 
hypoxic immature heart. Preexisting injury caused by 
acute hypoxia may be a prerequisite for reoxygenation 
injury in the studies described by Bolling's group. 1
Our laboratory has developed a rabbit model of hypoxia 
from birth that simulates the essential characteristics of
cyanotic heart disease: decreased arterial oxygen levels, 
polycythemia, increased right ventricular mass, decreased 
weight gain, and overall failure to thrive. 4 We have 
demonstrated that hypoxia from birth increases the toler- 
ance of the heart to ischemia compared with that of 
age-matched normoxic ontrol subjects. 4 The mechanism 
for adaptation to prolonged hypoxia that confers in- 
creased tolerance to subsequent myocardial ischemia is 
currently unknown. 
We have also examined the calcium content of St. 
Thomas' Hospital II cardioplegic solution and found in 
our model that the existing calcium content of 1.2 mmol/L 
is suboptimal to protect he ischemic immature myocar- 
dium. Optimal myocardial protection occurred with a 
calcium concentration of 0.4 mmo!/L in hearts chronically 
hypoxic from birth 5 and 0.3 mmol/L in hearts normoxic 
from birth. 6 These previously published ata may place in 
perspective the study by Bolling and coworkers, confirm- 
ing their hypothesis of hypocalcemic cardioplegia being 
superior to normocalcemic cardioplegia in protection of 
immature myocardium. The response, however, of imma- 
ture myocardium to acute versus chronic hypoxia before 
reoxygenation, with and without surgical ischemia, is 
speculative because neither we nor Bolling and his asso- 
ciates addressed this particular issue. 
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